作者: Daniel G. Coit
DOI: 10.1007/978-1-4615-3080-0_11
关键词:
摘要: Although cutaneous malignant melanoma comprises only 3% of all cancers, its incidence is rising more rapidly than any other malignancy, increasing 83% between 1973 and 1987. If this trend continues, it estimated that the lifetime risk developing for someone born in 1950, 1:600, will increase to 1:90 year 2000. Fortunately, 32,000 new cases diagnosed United States 1992, vast majority be as a surgically curable stage. Between 1981 1987, 80% melanomas were localized disease, with another 8% being locoregional disease [1]. Even at tertiary referral center, are stage when surgery represents mainstay therapy (Table 1). Thus, imperative we have complete thorough understanding surgical management these patients stages.